About:
ScaleReady is developing technology to improve the manufacturing of cell or gene therapies. Cell and gene therapies have much potential for patients, but it is not trivial to scale up from benchtop research to clinical doses. ScaleReady has used their innovations including their breakthrough G-Rex closed-system bioreactor, to make cell and gene therapy straightforward and cost effective. The G-Rex bioreactor reimagines 100 years of cell culture assumptions to make cell therapy manufacturing reproducible and scalable. By combining G-Rex with efficient cell processing instruments, ScaleReady can process multiple cell therapy products in a day.